Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 21,000 shares at $57.44 ($1.2M) on 2020-05-19, disclosed to the SEC on 2020-05-21.
Open-market sale of $1.2M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.33 | 1,200 | $68K | 5.4% |
| 2 | $57.44 | 2,400 | $138K | 11.1% |
| 3 | $58.36 | 3,000 | $175K | 14.1% |
| 4 | $58.94 | 400 | $24K | 1.9% |
| 5 | $59.04 | 500 | $30K | 2.4% |
| 6 | $60.03 | 5,100 |
| $306K |
| 24.6% |
| 7 | $60.98 | 1,400 | $85K | 6.9% |
| 8 | $59.64 | 6,900 | $412K | 33.1% |
| 9 | $60.34 | 100 | $6K | 0.5% |
| Total | $59.18 avg | 21,000 | $1.2M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |
| TPTX | SELL | 2020-04-24 | $1.5M | — | Filing → |